{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:37:40Z","timestamp":1790757460879,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T00:00:00Z","timestamp":1682640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Luzhou-Southwest Medical University Science and Technology Strategic Cooperation project","award":["2018LZXNYD-ZK46"],"award-info":[{"award-number":["2018LZXNYD-ZK46"]}]},{"name":"Natural Fund project of Luzhou Science and Technology Bureau","award":["2021JYJ-82"],"award-info":[{"award-number":["2021JYJ-82"]}]},{"name":"Planned Project of Sichuan Science and Technology Department","award":["2022NSFSC0816"],"award-info":[{"award-number":["2022NSFSC0816"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatocellular carcinoma (HCC) is a malignancy worldwide with one of the worst prognoses. Emerging studies have revealed that long noncoding RNAs (lncRNAs) contribute to HCC progression. This research probes the expression and regulatory effect of lncRNA SATB2-AS1 on HCC development. Reverse transcription-polymerase chain reaction (RT-PCR) was applied to measure the SATB2-AS1 profile in HCC tissues and adjacent non-tumor tissues. The impact of SATB2-AS1, miR-3678-3p, or GRIM-19 on HCC cell proliferation, growth, migration, invasion, and apoptosis was determined by gain- and loss-of-function experiments. The results revealed that SATB2-AS1 was downregulated in HCC tissues, and its lower levels were related to higher tumor staging and poorer prognosis of HCC patients. SATB2-AS1 overexpression repressed HCC cell proliferation, induced G1 arrest, and apoptosis, and inhibited migration, invasion, and epithelial-mesenchymal transition (EMT). Mechanistically, SATB2-AS1 inactivated STAT3\/HIF-1\u03b1 and strengthened GRIM-19 expression. After knocking down GRIM-19 with small interfering RNA (siRNA), the malignant phenotypes of HCC cells were enhanced. Further bioinformatics analysis showed that miR-3678-3p was targeted by SATB2-AS1. The dual-luciferase reporter assay, RNA immunoprecipitation (RIP) experiment, and Fluorescence in situ Hybridization (FISH) test confirmed that SATB2-AS1 sponged miR-3678-3p and the latter targeted GRIM-19. The rescue experiments showed that miR-3678-3p aggravated the malignant behaviors of HCC cells, whereas SATB2-AS1 overexpression reversed miR-3678-3p-mediated effects. Inhibition STAT3 promoted SATB2-AS1 and GRIM-19 expression, and reduced miR-3678-3p level. Activation STAT3 exerted opposite effects. Overall, this study confirmed that SATB2-AS1 is a potential prognostic biomarker for HCC and regulates HCC devolvement by regulating the miR-3678-3p\/GRIM-19\/STAT3\/HIF-1\u03b1 pathway.<\/jats:p>","DOI":"10.1186\/s12935-023-02901-1","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T14:02:42Z","timestamp":1682690562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["LncRNA SATB2-AS1 overexpression represses the development of hepatocellular carcinoma through regulating the miR-3678-3p\/GRIM-19 axis"],"prefix":"10.1186","volume":"23","author":[{"given":"Jiang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,28]]},"reference":[{"key":"2901_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00414","author":"J Huang","year":"2020","unstructured":"Huang J, Chen F, Zhong Z, Tan HY, Wang N, Liu Y, et al. Interpreting the pharmacological mechanisms of huachansu capsules on hepatocellular carcinoma through combining network pharmacology and experimental evaluation. Front Pharmacol. 2020. https:\/\/doi.org\/10.3389\/fphar.2020.00414.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2901_CR2","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12885-020-06822-4","volume":"20","author":"H Jo","year":"2020","unstructured":"Jo H, Park Y, Kim T, Kim J, Lee JS, Kim SY, et al. Modulation of SIRT3 expression through CDK4\/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells. BMC Cancer. 2020;20(1):332. https:\/\/doi.org\/10.1186\/s12885-020-06822-4.","journal-title":"BMC Cancer"},{"issue":"2","key":"2901_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ijc.32723","volume":"147","author":"JL Petrick","year":"2020","unstructured":"Petrick JL, Florio AA, Znaor A, Ruggieri D, Laversanne M, Alvarez CS, Ferlay J, Valery PC, Bray F, McGlynn KA. International trends in hepatocellular carcinoma incidence, 1978\u20132012. Int J Cancer. 2020;147(2):317\u201330. https:\/\/doi.org\/10.1002\/ijc.32723.","journal-title":"Int J Cancer"},{"issue":"5","key":"2901_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.21037\/atm.2020.01.93","volume":"8","author":"J Zheng","year":"2020","unstructured":"Zheng J, Zhu MY, Wu F, Kang B, Liang J, Heskia F, et al. A blood-based 22-gene expression signature for hepatocellular carcinoma identification. Ann Transl Med. 2020;8(5):195. https:\/\/doi.org\/10.21037\/atm.2020.01.93.","journal-title":"Ann Transl Med"},{"issue":"13","key":"2901_CR5","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.2147\/OTT.S247133","volume":"2","author":"L Yan","year":"2020","unstructured":"Yan L, Xu F, Dai C. Overexpression of COL24A1 in hepatocellular carcinoma predicts poor prognosis: a study based on multiple databases, clinical samples and cell lines. Onco Targets Ther. 2020;2(13):2819\u201332. https:\/\/doi.org\/10.2147\/OTT.S247133.","journal-title":"Onco Targets Ther"},{"issue":"46","key":"2901_CR6","doi-asserted-by":"publisher","first-page":"6728","DOI":"10.3748\/wjg.v25.i46.6728","volume":"25","author":"ZL Ou","year":"2019","unstructured":"Ou ZL, Luo Z, Lu YB. Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer. World J Gastroenterol. 2019;25(46):6728\u201342. https:\/\/doi.org\/10.3748\/wjg.v25.i46.6728.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"2901_CR7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s13577-020-00331-z","volume":"33","author":"W Huang","year":"2020","unstructured":"Huang W, Shi Y, Han B, Wang Q, Zhang B, Qi C, Liu F. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR-106b-5p\/TUSC2 axis. Hum Cell. 2020;33(2):416\u201326. https:\/\/doi.org\/10.1007\/s13577-020-00331-z.","journal-title":"Hum Cell"},{"issue":"11","key":"2901_CR8","doi-asserted-by":"publisher","first-page":"8517","DOI":"10.2147\/CMAR.S213707","volume":"20","author":"Z Luo","year":"2019","unstructured":"Luo Z, Cao P. Long noncoding RNA PVT1 promotes hepatoblastoma cell proliferation through activating STAT3. Cancer Manag Res. 2019;20(11):8517\u201327. https:\/\/doi.org\/10.2147\/CMAR.S213707.","journal-title":"Cancer Manag Res"},{"issue":"20","key":"2901_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12935-020-01411-8","volume":"17","author":"S Cheng","year":"2020","unstructured":"Cheng S, Xia B, Li H, Li Y, Lv X, Zhang Y, Huang Y. Long non-coding RNA SATB2-AS1 inhibits microRNA-155-3p to suppress breast cancer cell growth by promoting breast cancer metastasis suppressor 1-like. Cancer Cell Int. 2020;17(20):321. https:\/\/doi.org\/10.1186\/s12935-020-01411-8.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"2901_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12943-019-1063-6","volume":"18","author":"M Xu","year":"2019","unstructured":"Xu M, Xu X, Pan B, Chen X, Lin K, Zeng K, et al. LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2. Mol Cancer. 2019;18(1):135. https:\/\/doi.org\/10.1186\/s12943-019-1063-6.","journal-title":"Mol Cancer"},{"issue":"5","key":"2901_CR11","doi-asserted-by":"publisher","first-page":"429","DOI":"10.2174\/138920101505140828161335","volume":"15","author":"Y Tutar","year":"2014","unstructured":"Tutar Y. miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol. 2014;15(5):429. https:\/\/doi.org\/10.2174\/138920101505140828161335.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"2901_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s13046-019-1421-7","volume":"38","author":"K Qiao","year":"2019","unstructured":"Qiao K, Ning S, Wan L, Wu H, Wang Q, Zhang X, Xu S, Pang D. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p\/MARK4\/Hippo signaling pathway. J Exp Clin Cancer Res. 2019;38(1):418. https:\/\/doi.org\/10.1186\/s13046-019-1421-7.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2901_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3892\/or.2015.4392","volume":"35","author":"C Xu","year":"2016","unstructured":"Xu C, Li S, Chen T, Hu H, Ding C, Xu Z, et al. miR-296\u20135p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer. Oncol Rep. 2016;35(1):497\u2013503. https:\/\/doi.org\/10.3892\/or.2015.4392.","journal-title":"Oncol Rep"},{"issue":"1","key":"2901_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12967-018-1492-9","volume":"16","author":"J Slotta-Huspenina","year":"2018","unstructured":"Slotta-Huspenina J, Drecoll E, Feith M, Habermehl D, Combs S, Weichert W, et al. MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus. J Transl Med. 2018;16(1):109. https:\/\/doi.org\/10.1186\/s12967-018-1492-9.","journal-title":"J Transl Med"},{"issue":"1","key":"2901_CR15","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.3892\/ol.2017.6266","volume":"14","author":"M Lin","year":"2017","unstructured":"Lin M, Duan B, Hu J, Yu H, Sheng H, Gao H, Huang J. Decreased expression of miR-193a-3p is associated with poor prognosis in colorectal cancer. Oncol Lett. 2017;14(1):1061\u20137.","journal-title":"Oncol Lett"},{"issue":"Pt 16","key":"2901_CR16","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1242\/jcs.070250","volume":"123","author":"ER Hofmann","year":"2010","unstructured":"Hofmann ER, Nallar SC, Lin L, et al. Identification and characterization of GRIM-1, a cell-death-associated gene product. J Cell Sci. 2010;123(Pt 16):2781\u201391.","journal-title":"J Cell Sci"},{"issue":"8","key":"2901_CR17","doi-asserted-by":"publisher","first-page":"12800","DOI":"10.1002\/jcp.27914","volume":"234","author":"J Zhang","year":"2019","unstructured":"Zhang J, Chu D, Kawamura T, Tanaka K, He S. GRIM-19 repressed hypoxia-induced invasion and EMT of colorectal cancer by repressing autophagy through inactivation of STAT3\/HIF-1\u03b1 signaling axis. J Cell Physiol. 2019;234(8):12800\u20138. https:\/\/doi.org\/10.1002\/jcp.27914.","journal-title":"J Cell Physiol"},{"issue":"688","key":"2901_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.gene.2018.11.021","volume":"10","author":"H Lin","year":"2019","unstructured":"Lin H, Lin T, Lin J, Yang M, Shen Z, Liu H, et al. Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19. Gene. 2019;10(688):93\u20137. https:\/\/doi.org\/10.1016\/j.gene.2018.11.021.","journal-title":"Gene"},{"issue":"6","key":"2901_CR19","doi-asserted-by":"publisher","first-page":"e28307","DOI":"10.1002\/pbc.28307","volume":"67","author":"AM D'Souza","year":"2020","unstructured":"D\u2019Souza AM, Towbin AJ, Gupta A, Alonso M, Nathan JD, Bondoc A, et al. Clinical heterogeneity of pediatric hepatocellular carcinoma. Pediatr Blood Cancer. 2020;67(6):e28307. https:\/\/doi.org\/10.1002\/pbc.28307.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2901_CR20","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3892\/or.2020.7585","volume":"44","author":"X Chen","year":"2020","unstructured":"Chen X, Zhao W, Fan W. Long non-coding RNA GHET1 promotes osteosarcoma development and progression via Wnt\/\u03b2-catenin signaling pathway. Oncol Rep. 2020;44(1):349\u201359. https:\/\/doi.org\/10.3892\/or.2020.7585.","journal-title":"Oncol Rep"},{"issue":"14","key":"2901_CR21","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1158\/0008-5472.CAN-18-2900","volume":"79","author":"YQ Wang","year":"2019","unstructured":"Wang YQ, Jiang DM, Hu SS, Zhao L, Wang L, Yang MH, et al. SATB2-AS1 suppresses colorectal carcinoma aggressiveness by Inhibiting SATB2-dependent snail transcription and epithelial-mesenchymal transition. Cancer Res. 2019;79(14):3542\u201356. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-2900.","journal-title":"Cancer Res"},{"issue":"14","key":"2901_CR22","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.1158\/0008-5472.CAN-19-1205","volume":"79","author":"C Li","year":"2019","unstructured":"Li C. New functions of long noncoding RNAs during EMT and tumor progression. Cancer Res. 2019;79(14):3536\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1205.","journal-title":"Cancer Res"},{"issue":"1\u20132","key":"2901_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11010-017-2953-9","volume":"430","author":"SH Liu","year":"2017","unstructured":"Liu SH, Zhu JW, Xu HH, Zhang GQ, Wang Y, Liu YM, et al. A novel antisense long non-coding RNA SATB2-AS1 overexpresses in osteosarcoma and increases cell proliferation and growth. Mol Cell Biochem. 2017;430(1\u20132):47\u201356. https:\/\/doi.org\/10.1007\/s11010-017-2953-9.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"2901_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13046-020-01825-2","volume":"40","author":"JJ Hu","year":"2021","unstructured":"Hu JJ, Zhou C, Luo X, Luo SZ, Li ZH, Xu ZX, et al. Linc-SCRG1 accelerates progression of hepatocellular carcinoma as a ceRNA of miR26a to derepress SKP2. J Exp Clin Cancer Res. 2021;40(1):26. https:\/\/doi.org\/10.1186\/s13046-020-01825-2.","journal-title":"J Exp Clin Cancer Res"},{"issue":"12","key":"2901_CR25","doi-asserted-by":"publisher","first-page":"10749","DOI":"10.2147\/CMAR.S263619","volume":"29","author":"Z Liu","year":"2020","unstructured":"Liu Z, Li Z, Xu B, Yao H, Qi S, Tai J. Long noncoding RNA PRR34-AS1 aggravates the progression of hepatocellular carcinoma by adsorbing microRNA-498 and thereby upregulating FOXO3. Cancer Manag Res. 2020;29(12):10749\u201362. https:\/\/doi.org\/10.2147\/CMAR.S263619.","journal-title":"Cancer Manag Res"},{"issue":"6","key":"2901_CR26","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.amjms.2020.08.010","volume":"360","author":"X Liu","year":"2020","unstructured":"Liu X, Shen Z. LncRNA TMPO-AS1 aggravates the development of hepatocellular carcinoma via miR-429\/GOT1 Axis. Am J Med Sci. 2020;360(6):711\u201320. https:\/\/doi.org\/10.1016\/j.amjms.2020.08.010.","journal-title":"Am J Med Sci"},{"issue":"3","key":"2901_CR27","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/jcp.24025","volume":"227","author":"H Hao","year":"2012","unstructured":"Hao H, Liu J, Liu G, Guan D, Yang Y, Zhang X, et al. Depletion of GRIM-19 accelerates hepatocellular carcinoma invasion via inducing EMT and loss of contact inhibition. J Cell Physiol. 2012;227(3):1212\u20139. https:\/\/doi.org\/10.1002\/jcp.24025.","journal-title":"J Cell Physiol"},{"issue":"11","key":"2901_CR28","first-page":"7497","volume":"7","author":"D Kong","year":"2014","unstructured":"Kong D, Zhao L, Du Y, He P, Zou Y, Yang L, et al. Overexpression of GRIM-19, a mitochondrial respiratory chain complex I protein, suppresses hepatocellular carcinoma growth. Int J Clin Exp Pathol. 2014;7(11):7497\u2013507.","journal-title":"Int J Clin Exp Pathol"},{"issue":"8","key":"2901_CR29","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1093\/carcin\/bgt125","volume":"34","author":"Q Liu","year":"2013","unstructured":"Liu Q, Wang L, Wang Z, Yang Y, Tian J, Liu G, et al. GRIM-19 opposes reprogramming of glioblastoma cell metabolism via HIF1\u03b1 destabilization. Carcinogenesis. 2013;34(8):1728\u201336. https:\/\/doi.org\/10.1093\/carcin\/bgt125.","journal-title":"Carcinogenesis"},{"issue":"4","key":"2901_CR30","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5582\/bst.2019.01185","volume":"13","author":"D Kong","year":"2019","unstructured":"Kong D, Chen J, Sun X, Lin Y, Du Y, Huang D, et al. GRIM-19 over-expression represses the proliferation and invasion of orthotopically implanted hepatocarcinoma tumors associated with downregulation of Stat3 signaling. Biosci Trends. 2019;13(4):342\u201350. https:\/\/doi.org\/10.5582\/bst.2019.01185.","journal-title":"Biosci Trends"},{"issue":"5","key":"2901_CR31","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1007\/s12032-012-0234-8","volume":"29","author":"F Li","year":"2012","unstructured":"Li F, Ren W, Zhao Y, Fu Z, Ji Y, Zhu Y, Qin C. Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma. Med Oncol. 2012;29(5):3046\u201354. https:\/\/doi.org\/10.1007\/s12032-012-0234-8.","journal-title":"Med Oncol"},{"issue":"1","key":"2901_CR32","doi-asserted-by":"publisher","first-page":"101","DOI":"10.18632\/oncotarget.2684","volume":"6","author":"XY Zhang","year":"2015","unstructured":"Zhang XY, Li M, Sun K, Chen XJ, Meng J, Wu L, et al. Decreased expression of GRIM-19 by DNA hypermethylation promotes aerobic glycolysis and cell proliferation in head and neck squamous cell carcinoma. Oncotarget. 2015;6(1):101\u201315. https:\/\/doi.org\/10.18632\/oncotarget.2684.","journal-title":"Oncotarget"},{"issue":"8","key":"2901_CR33","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1016\/j.bbagen.2017.05.009","volume":"1861","author":"S Aghazadeh","year":"2017","unstructured":"Aghazadeh S, Yazdanparast R. Activation of STAT3\/HIF-1\u03b1\/Hes-1 axis promotes trastuzumab resistance in HER2-overexpressing breast cancer cells via down-regulation of PTEN. Biochim Biophys Acta Gen Subj. 2017;1861(8):1970\u201380.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"6","key":"2901_CR34","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.3892\/ijo.2014.2367","volume":"44","author":"A Nishimoto","year":"2014","unstructured":"Nishimoto A, Kugimiya N, Hosoyama T, Enoki T, Li TS, Hamano K. HIF-1\u03b1 activation under glucose deprivation plays a central role in the acquisition of anti-apoptosis in human colon cancer cells. Int J Oncol. 2014;44(6):2077\u201384.","journal-title":"Int J Oncol"},{"issue":"12","key":"2901_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244255","volume":"15","author":"M Grillo","year":"2020","unstructured":"Grillo M, Palmer C, Holmes N, et al. Stat3 oxidation-dependent regulation of gene expression impacts on developmental processes and involves cooperation with Hif-1\u03b1. PLoS ONE. 2020;15(12): e0244255.","journal-title":"PLoS ONE"},{"issue":"6692","key":"2901_CR36","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/28867","volume":"394","author":"P Carmeliet","year":"1998","unstructured":"Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998;394(6692):485\u201390.","journal-title":"Nature"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-023-02901-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-023-02901-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-023-02901-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T14:03:34Z","timestamp":1682690614000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-023-02901-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,28]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2901"],"URL":"https:\/\/doi.org\/10.1186\/s12935-023-02901-1","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,28]]},"assertion":[{"value":"4 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiment received the green light from the Ethics Committee of Luzhou People\u2019s Hospital (Approval number: LZHEC-2015-012), and all participants voluntarily signed the informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"82"}}